We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?
- Authors
van Keulen, Anne-Marleen; Olthof, Pim B.; Cescon, Matteo; Guglielmi, Alfredo; Jarnagin, William R.; Nadalin, Silvio; Pratschke, Johann; Ratti, Francesca; Troisi, Roberto I.; Groot Koerkamp, Bas; Buettner, Stefan; Erdmann, Joris I.
- Abstract
Simple Summary: Long-term survival for patients with perihilar cholangiocarcinoma (pCCA) is rare. The median overall survival of patients undergoing curative-intent surgery for pCCA is 19 to 39 months. This multicenter study aimed to determine the cure rate and to identify clinicopathological factors that may preclude cure. Four hundred and sixty patients were included with a median follow-up of 10 years. Median OS was 29.9 months. Twenty-nine (6%) patients reached 10-year OS. The observed cure rate was 5%. Factors that virtually precluded cure (i.e., below 1%) according to the mixture cure model included age above 70, Bismuth–Corlette type IV tumors, hepatic artery reconstruction, and positive resection margins. Cure was unlikely (i.e., below 3%) in patients with positive lymph nodes or poor tumor differentiation. These factors need to be considered in patient counseling and long-term follow-up after surgery. Complete resection of perihilar cholangiocarcinoma (pCCA) is the only potentially curative treatment. Long-term survival data is rare and prognostic analyses are hindered by the rarity of the disease. This study aimed to determine the cure rate and to identify clinicopathological factors that may preclude cure. All consecutive resections for pathologically confirmed pCCA between 2000 and 2009 in 22 centers worldwide were included in a retrospective cohort study. Each center included its retrospective data series. A total of 460 patients were included with a median follow-up of 10 years for patients alive at last follow-up. Median overall survival (OS) was 29.9 months and 10-year OS was 12.8%. Twenty-nine (6%) patients reached 10-year OS. The observed cure rate was 5%. Factors that virtually precluded cure (i.e., below 1%) according to the mixture cure model included age above 70, Bismuth-Corlette type IV tumors, hepatic artery reconstruction, and positive resection margins. Cure was unlikely (i.e., below 3%) in patients with positive lymph nodes or poor tumor differentiation. These factors need to be considered in patient counseling and long-term follow-up after surgery.
- Subjects
SURVIVAL; RESEARCH; BILE duct adenocarcinoma; MEDICAL cooperation; CANCER patients; SURVIVAL analysis (Biometry); DESCRIPTIVE statistics
- Publication
Cancers, 2021, Vol 13, Issue 24, p6260
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers13246260